Publications 2020 – 2018
2020 | 2019 | 2018 | 2015 thru 2017 | 2014 thru 2010 | 2009 thru 2005 | 2004 thru 2001
2020
Akter F, Simon B, de Boer NL, Redjal N, Wakimoto H, Shah K. Pre-clinical tumor models of primary brain tumors: Challenges and opportunities. Biochim Biophys Acta Rev Cancer. 2020 Oct 23;1875(1):188458. doi: 10.1016/j.bbcan.2020.188458. Online ahead of print. PMID: 33148506.
Jiang L, Wang YJ, Zhao J, Uehara M, Hou Q, Kasinath V, Ichimura T, Banouni N, Dai L, Li X, Greiner DL, Shultz LD, Zhang X, Sun ZJ, Curtin I, Vangos NE, Yeoh ZC, Geffken EA, Seo HS, Liu ZX, Heffron GJ, Shah K, Dhe-Paganon S, Abdi R. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy. Cell. 2020 Nov 25;183(5):1219-1233.e18. doi: 10.1016/j.cell.2020.10.045. PMID: 33242418.
Kiyokawa J, Kawamura Y, Ghouse SM, Acar S, Barçın E, Martínez-Quintanilla J, Martuza RL, Alemany R, Rabkin SD, Shah K, Wakimoto H. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma. Clin Cancer Res. 2020 Nov 30. doi: 10.1158/1078-0432.CCR-20-2400. Online ahead of print. PMID: 33257429.
Yang EY, Shah K. Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics. Frontiers in Oncology 2020 Jul 23;10:1182. doi: 10.3389/fonc.2020.01182.. PMID: 32793488.
Khalsa JK, Cheng N, Keegan J, Chaudry A, Driver J, Bi WL, Lederer J, Shah, K. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nature Communication 2020 Aug 6;11(1):3912. doi: 10.1038/s41467-020-17704-5. PMID: 32764562.
Deng D, Shah K. TRAIL of hope meeting resistance in cancer. Trends in Cancer 2020 Jul 24;S2405-8033(20)30190-4. doi: 10.1016/j.trecan.2020.06.006. PMID: 32718904.
Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends in Pharmacological Sciences 2020 Jul 22;S0165-6147(20)30145-0. doi: 10.1016/j.tips.2020.06.009. PMID: 32709406.
Levy O, Kuai R, Siren E, Bhere D, Milton Y, Nissar N, De Biasio M, Heinelt M, Reeve B, Abdi R, Alturki M, Fallatah M, Almalik A, Alhasan AH, Shah K*, Karp JM. Shattering barriers toward clinically meaningful MSC therapies. Science Advances 2020 Jul 22;6(30):eaba6884. doi: 10.1126/sciadv.aba6884. * Co-corresponding author. PMID: 32832666.
Mineo M, Lyons SM, Zdioruk M, von Spreckelsen N, Ferrer-Luna R, Ito H, Alayo QA, Kharel P, Giantini Larsen A, Fan WY, Auduong S, Grauwet K, Passaro C, Khalsa JK, Shah K, Reardon DA, Ligon KL, Beroukhim R, Nakashima H, Ivanov P, Anderson PJ, Lawler SE, Chiocca EA. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed From the PD-L1 Locus. Molecular Cell. 2020 Jun. 18. doi: 10.1016/j.molcel.2020.05.015. PMID: 32504554.
Karakas N, Bay S, Türkel N, Öztunç N, Öncül M, Bilgen H, Shah K, Şahin F, Öztürk, G. Neurons from human mesenchymal stem cells display both spontaneous and stimuli responsive activity. PLoS One. 2020 May 14. doi: 10.1371/journal.pone.0228510. PMID: 32407317.
Lee YH, Pang SW, Révai Lechtich E, Shah K, Simon SE, Ponnusamy S, Narayanan R, Poh CL, Tan KO. Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1. Journal of Clinical Research and Clinical Oncology. 2020 May 6. doi: 10.1007/s00432-020-03231-9. PMID: 32377840.
Bhere D, Arghiani N, Révai Lechtich E, Yao Y, Alsaab S, Bei F, Matin MM, Shah K. Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy. Scientific Reports. 2020 Feb. 4. doi: 10.1038/s41598-020-58072-w. PMID: 32019988.
Yang Q, Luo C, Zhang X, Liu Y, Wang Z, Cacciamani P, Shi J, Cui Y, Wang C, Sinha B, Peng B, Tong G, Das G, Shah E, Gao Y, Li W, Tu Y, Qian D, Shah K, Akbar M, Zhou S, Song BJ, Wang X. Tartary buckwheat extract alleviates alcohol-induced acute and chronic liver injuries through the inhibition of oxidative stress and mitochondrial cell death pathway. American Journal of Translational Research. 2020 Jan. 15. e-collection PMID: 32051738.
Kavari SL, Shah K. Concise Review: Engineered Stem Cells Targeting Multiple Cell Surface Receptors in Tumors. Stem Cells 2020 Jan. doi: 10.1002/stem.3069. PMID: 31381835.
2019
Kuruppu D, Bhere D, Farrar CT, Shah K, Brownell AL, Tanabe KK. A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging. Cancer Gene Therapy 2019 May 26. doi: 10.1038/s41417-018-0060-z PMID: 30420717.
Martinez-Quintanilla J, Seah I, Chua M, Shah K. Oncolytic viruses: overcoming translational challenges. Journal of Clinical Investigation 2019 Mar. 4. doi: 10.1172/JCI122287. PMID: 30829653.
Tanaka S, Luk S, Kiyokawa J, Onozato ML, Iafrate AJ, Shah K, Martuza RL, Rabkin SD, Batchelor TT, Cahill DP, Chi AS, Wakimoto H. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Scientific Reports 2019 Jan. 15. doi: 10.1038/s41598-018-37437-2. PMID: 30644426.
Passaro, C, Alayo Q, De Laura I, McNulty J, Grauwet K, Ito H, Bhaskaran V, Mineo M, Lawler SE, Shah K, Speranza MC, Goins W, McLaughlin E, Fernandez S, Reardon DA, Freeman GJ, Chiocca EA, Nakashima H. Arming an oncolytic herpes simplex virus type 1 with a single chain variable antibody against PD-1 for experimental glioblastoma therapy. Clinical Cancer Research 2019 Jan. 1. doi: 10.1158/1078-0432.CCR-18-2311. PMID: 30279232.
2018
Reinshagen C, Bhere D, Choi SH, Hutten S, Nesterenko I, Wakimoto H, Le Roux E, Rizvi A, Du W, Minicucci C, Shah K. CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors. Science Translational Medicine. 2018 Jul. 11. doi: 10.1126/scitranslmed.aao3240. PMID: 29997250.
Bhere D, Khajuria RK, Hendriks WT, Bandyopadhyay A, Bagci-Onder T, Shah K. Therapeutic Neural Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies. Stem Cells. 2018 Jun. doi: 10.1002/stem.2805. PMID: 29451340.
Heidari P, Kunawudhi A, Martinez-Quintanilla J, Szretter A, Shah K, Mahmood U. Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions. Theranostics. 2018 May 23. doi: 10.7150/thno.24017. PMID: 29930736.
Bhere D, Tamura K, Wakimoto H, Choi SH, Purow B, Debatisse J, Shah K. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis. Neuro Oncolology. 2018 Jan 22. doi: 10.1093/neuonc/nox138. PMID: 29016934.